Emerging Roles of Protein Kinase D1 in Cancer

Protein kinase D1 (PKD1) is a serine-threonine kinase that regulates various functions within the cell, including cell proliferation, apoptosis, adhesion, and cell motility. In normal cells, this protein plays key roles in multiple signaling pathways by relaying information from the extracellular environment and/or upstream kinases and converting them into a regulated intracellular response. The aberrant expression of PKD1 is associated with enhanced cancer phenotypes, such as deregulated cell proliferation, survival, motility, and epithelial mesenchymal transition. In this review, we summarize the structural and functional aspects of PKD1 and highlight the pathobiological roles of this kinase in cancer. Mol Cancer Res; 9(8); 985–96. ©2011 AACR.

[1]  P. Storz,et al.  Mitochondrial diacylglycerol initiates protein-kinase-D1-mediated ROS signaling , 2009, Journal of Cell Science.

[2]  W. Isaacs,et al.  Androgen receptor outwits prostate cancer drugs , 2004, Nature Medicine.

[3]  S. Hassan,et al.  Heat shock protein 27 mediates repression of androgen receptor function by protein kinase D1 in prostate cancer cells , 2009, Oncogene.

[4]  Lynette M. Smith,et al.  Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. , 2005, Urologic oncology.

[5]  H. Katz,et al.  Activation of Protein Kinase D1 in Mast Cells in Response to Innate, Adaptive, and Growth Factor Signals1 , 2007, The Journal of Immunology.

[6]  P. Rao,et al.  Protein kinase C μ is down-regulated in androgen-independent prostate cancer , 2003 .

[7]  K. Pfizenmaier,et al.  PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration , 2007, FEBS letters.

[8]  María Martín,et al.  Ongoing and future developments at the Universal Protein Resource , 2010, Nucleic Acids Res..

[9]  R. Unger,et al.  Adhesion of renal carcinoma cells to endothelial cells depends on PKCμ , 2010, BMC Cancer.

[10]  Meena Jaggi,et al.  Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer. , 2003, Biochemical and biophysical research communications.

[11]  V. Malhotra,et al.  Protein kinase D: an intracellular traffic regulator on the move. , 2002, Trends in cell biology.

[12]  Chang Hoon Ha,et al.  VEGF Stimulates HDAC7 Phosphorylation and Cytoplasmic Accumulation Modulating Matrix Metalloproteinase Expression and Angiogenesis , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Peter Storz,et al.  Protein kinase D mediates a stress‐induced NF‐κB activation and survival pathway , 2003, The EMBO journal.

[14]  A. Newton,et al.  The Protein Scaffold NHERF-1 Controls the Amplitude and Duration of Localized Protein Kinase D Activity* , 2009, The Journal of Biological Chemistry.

[15]  T. Iglesias,et al.  Protein Kinase D Intracellular Localization and Activity Control Kinase D-interacting Substrate of 220-kDa Traffic through a Postsynaptic Density-95/Discs Large/Zonula Occludens-1-binding Motif* , 2006, Journal of Biological Chemistry.

[16]  E. Rozengurt,et al.  Role of protein kinase D signaling in pancreatic cancer. , 2010, Biochemical pharmacology.

[17]  M. Jaggi,et al.  Bryostatin 1 modulates β-catenin subcellular localization and transcription activity through protein kinase D1 activation , 2008, Molecular Cancer Therapeutics.

[18]  Hua Tang,et al.  Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. , 2009, American journal of physiology. Cell physiology.

[19]  K. Pfizenmaier,et al.  Protein Kinase D Controls Actin Polymerization and Cell Motility through Phosphorylation of Cortactin* , 2010, The Journal of Biological Chemistry.

[20]  E. Rozengurt,et al.  Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. , 2002, Cancer research.

[21]  O. Krämer,et al.  Inhibitors of HDACs--effective drugs against cancer? , 2010, Current cancer drug targets.

[22]  P. Storz,et al.  Protein Kinase D1 regulates Cofilin mediated F-actin reorganization and cell motility via Slingshot , 2009, Nature Cell Biology.

[23]  Zhou Songyang,et al.  Determination of the Specific Substrate Sequence Motifs of Protein Kinase C Isozymes* , 1997, The Journal of Biological Chemistry.

[24]  K. Pfizenmaier,et al.  Protein kinase D regulates cell migration by direct phosphorylation of the cofilin phosphatase slingshot 1 like. , 2009, Cancer research.

[25]  E. Rozengurt,et al.  TNF-α potentiates lysophosphatidic acid-induced COX-2 expression via PKD in human colonic myofibroblasts. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[26]  Gang Wang,et al.  Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer. , 2008, Cancer research.

[27]  E. Olson,et al.  Protein Kinase D-dependent Phosphorylation and Nuclear Export of Histone Deacetylase 5 Mediates Vascular Endothelial Growth Factor-induced Gene Expression and Angiogenesis* , 2008, Journal of Biological Chemistry.

[28]  E. Rozengurt,et al.  Sequential Protein Kinase C (PKC)-dependent and PKC-independent Protein Kinase D Catalytic Activation via Gq-coupled Receptors , 2008, Journal of Biological Chemistry.

[29]  B. Aggarwal,et al.  A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo , 2010, Molecular Cancer Therapeutics.

[30]  E. Rozengurt,et al.  Protein kinase D in small cell lung cancer cells: rapid activation through protein kinase C. , 1999, Cancer research.

[31]  T. Seufferlein,et al.  Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling. , 2005, Molecular biology of the cell.

[32]  W. Klapper,et al.  PKCμ prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells , 2003, Oncogene.

[33]  S. Steinberg,et al.  Protein Kinase D1 Autophosphorylation via Distinct Mechanisms at Ser744/Ser748 and Ser916* , 2009, Journal of Biological Chemistry.

[34]  Shivendra V. Singh,et al.  Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. , 2008, Cancer research.

[35]  D. Vertommen,et al.  Regulation of Protein Kinase D by Multisite Phosphorylation , 2000, The Journal of Biological Chemistry.

[36]  N. Oue,et al.  Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase , 2010, Oncogene.

[37]  M. Jaggi,et al.  Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. , 2009, Cancer research.

[38]  S. Hassan,et al.  Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail. , 2010, Cancer research.

[39]  P. Rao,et al.  Protein kinase C mu is down-regulated in androgen-independent prostate cancer. , 2003, Biochemical and biophysical research communications.

[40]  D. Thomas,et al.  An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation , 1999, Oncogene.

[41]  P. Wipf,et al.  Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility , 2010, BMC chemical biology.

[42]  M. Avkiran,et al.  Protein kinase d in the cardiovascular system: emerging roles in health and disease. , 2008, Circulation research.

[43]  A. Toker,et al.  Phosphorylation of the Par-1 polarity kinase by protein kinase D regulates 14-3-3 binding and membrane association , 2008, Proceedings of the National Academy of Sciences.

[44]  S. Goodison,et al.  Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion , 2009, Breast Cancer Research.

[45]  Á. Valverde,et al.  Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Jaggi,et al.  Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells. , 2008, Biochemical and biophysical research communications.

[47]  E. Rozengurt,et al.  Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC‐1 cells , 2010, Journal of cellular physiology.

[48]  Peter Storz,et al.  Mitochondrial ROS--radical detoxification, mediated by protein kinase D. , 2007, Trends in cell biology.

[49]  W. Bollag,et al.  Protein kinase D and keratinocyte proliferation. , 2004, Drug news & perspectives.

[50]  A. Woods,et al.  PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. , 2004, The EMBO journal.

[51]  W. Bollag,et al.  Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis , 2006, The British journal of dermatology.

[52]  Lewis C Cantley,et al.  A rapid method for determining protein kinase phosphorylation specificity , 2004, Nature Methods.

[53]  E. Rozengurt.  Mitogenic signaling pathways induced by G protein‐coupled receptors , 2007, Journal of cellular physiology.

[54]  E. Rozengurt,et al.  Uncoupling of protein kinase D from suppression of EGF-dependent c-Jun phosphorylation in cancer cells. , 2003, Biochemical and biophysical research communications.

[55]  J. Prestle,et al.  PKCu is a novel, atypical member of the protein kinase C family. , 1994, The Journal of biological chemistry.

[56]  P. Wipf,et al.  Protein kinase D as a potential new target for cancer therapy. , 2010, Biochimica et biophysica acta.

[57]  T. Seufferlein,et al.  Protein kinase D: a family affair , 2003, FEBS letters.

[58]  M. Jaggi,et al.  Protein kinase D1: a protein of emerging translational interest. , 2007, Frontiers in bioscience : a journal and virtual library.

[59]  Seung-Moo Noh,et al.  Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. , 2007, Carcinogenesis.

[60]  Zeynep F. Altun,et al.  Neuronal and Intestinal Protein Kinase D Isoforms Mediate Na+ (Salt Taste)–Induced Learning , 2009, Science Signaling.

[61]  P. Mak,et al.  β‐catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E‐cadherin and protein kinase D1 , 2008, Journal of cellular biochemistry.

[62]  Jon W. Huss,et al.  BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources , 2009, Genome Biology.

[63]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[64]  S. H. Young,et al.  Protein Kinase Cν/Protein Kinase D3 Nuclear Localization, Catalytic Activation, and Intracellular Redistribution in Response to G Protein-coupled Receptor Agonists* , 2003, Journal of Biological Chemistry.

[65]  A. Toker,et al.  A Phosphorylation State-specific Antibody Recognizes Hsp27, a Novel Substrate of Protein Kinase D* , 2005, Journal of Biological Chemistry.

[66]  W. Bollag,et al.  ULTRAVIOLET B IRRADIATION AND ACTIVATION OF PROTEIN KINASE D IN PRIMARY MOUSE EPIDERMAL KERATINOCYTES , 2010, Oncogene.

[67]  E. Rozengurt,et al.  Protein Kinase D Signaling* , 2005, Journal of Biological Chemistry.

[68]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[69]  T. Seufferlein,et al.  Characterization of cortactin as an in vivo protein kinase D substrate: interdependence of sites and potentiation by Src. , 2009, Cellular signalling.

[70]  L. Languino,et al.  Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer. , 2010, Cancer research.

[71]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[72]  E. Rozengurt,et al.  PKD, PKD2, and p38 MAPK mediate Hsp27 serine‐82 phosphorylation induced by neurotensin in pancreatic cancer PANC‐1 cells , 2008, Journal of cellular biochemistry.

[73]  S. Ghazizadeh,et al.  Protein Kinase D Is Implicated in the Reversible Commitment to Differentiation in Primary Cultures of Mouse Keratinocytes* , 2010, The Journal of Biological Chemistry.

[74]  Lynette M. Smith,et al.  Metallothioneins and resistance to cisplatin and radiation in prostate cancer. , 2006, Urology.

[75]  A. Woods,et al.  PKD1/PKCμ promotes αvβ3 integrin recycling and delivery to nascent focal adhesions , 2004 .

[76]  P. Rao,et al.  E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. , 2005, Cancer research.

[77]  V. Malhotra,et al.  Protein Kinase D Regulates Trafficking of Dendritic Membrane Proteins in Developing Neurons , 2008, The Journal of Neuroscience.

[78]  E. Rozengurt,et al.  Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. , 2003, Cancer research.